<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(Suppl )</volume><submitter>Leabman M</submitter><journal>HemaSphere</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9429641</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA</pubmed_title><pmcid>PMC9429641</pmcid><pubmed_authors>Qazi I</pubmed_authors><pubmed_authors>Leabman M</pubmed_authors><pubmed_authors>So J</pubmed_authors><pubmed_authors>Budde E</pubmed_authors><pubmed_authors>Gopal A</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Takimoto C</pubmed_authors><pubmed_authors>Hart K</pubmed_authors><pubmed_authors>Kotturi M</pubmed_authors><pubmed_authors>Tang J</pubmed_authors><pubmed_authors>Hernandez G</pubmed_authors><pubmed_authors>Kim W</pubmed_authors><pubmed_authors>Keyt B</pubmed_authors><pubmed_authors>Sinclair A</pubmed_authors><pubmed_authors>Manley T</pubmed_authors><pubmed_authors>Ng C</pubmed_authors><pubmed_authors>Hinton P</pubmed_authors><pubmed_authors>Pandya D</pubmed_authors><pubmed_authors>Cheah C</pubmed_authors><pubmed_authors>Carroll S</pubmed_authors></additional><is_claimable>false</is_claimable><name>P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-05T11:02:56.264Z</modification><creation>2025-02-19T02:49:22.311Z</creation></dates><accession>S-EPMC9429641</accession><cross_references/></HashMap>